Medigene

Medigene is a listed biopharmaceutical company headquartered in Munich that develops and commercialises novel drugs against cancer and autoimmune diseases

  • Medigene acquired Trianta Immunotherapies, a transformational deal that boosts Medigene’s pipeline through three innovative immunotherapy platforms with clinical development programs to treat cancer
  • Kempen & Co acted as sole financial adviser to Medigene
Disclaimer Kempen Privacy statement Kempen Disclaimer Kempen & Co Privacy statement Kempen & Co Statement under the UK Modern Slavery Act Cookie Settings
Kempen & Co is a trade name of Van Lanschot Kempen NV. Kempen Capital Management NV is part of Van Lanschot Kempen NV.